Antipsychotics and Metabolic Syndrome | NCT00636753 | Trialant
SuspendedObservationalUpdated Jul 30, 2010
Antipsychotics and Metabolic Syndrome
ClinicalTrials.gov ID
NCT00636753
Lead Sponsor
Glostrup University Hospital, CopenhagenOTHER
Overall Status
Suspended
Study Type
Observational
Enrollment
60Estimated
Last Update Posted
Jul 30, 2010Estimated
Start Date
Sep 2008
Primary Completion Date
Jul 2009Estimated
Brief Summary
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.